X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (13) 13
cardiac & cardiovascular systems (7) 7
female (6) 6
humans (6) 6
index medicus (6) 6
internal medicine (6) 6
male (6) 6
aged (5) 5
bivalirudin (5) 5
coronary vessels (5) 5
heart attacks (5) 5
middle aged (5) 5
mortality (5) 5
percutaneous coronary intervention (5) 5
ticlopidine - analogs & derivatives (5) 5
abridged index medicus (4) 4
acute coronary syndromes (4) 4
adenosine monophosphate - analogs & derivatives (4) 4
cangrelor (4) 4
cardiac patients (4) 4
cardiology and cardiovascular medicine (4) 4
cardiovascular disease (4) 4
champion phoenix (4) 4
clopidogrel (4) 4
double-blind method (4) 4
pci (4) 4
platelet inhibition (4) 4
transluminal angioplasty (4) 4
treatment outcome (4) 4
adenosine monophosphate - administration & dosage (3) 3
adenosine monophosphate - adverse effects (3) 3
anticoagulants (3) 3
antiplatelet therapy (3) 3
cardiology (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
confidence intervals (3) 3
continuing medical education (3) 3
hemorrhage - chemically induced (3) 3
medical colleges (3) 3
patients (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
risk factors (3) 3
stent thrombosis (3) 3
thrombosis (3) 3
ticlopidine - administration & dosage (3) 3
ticlopidine - adverse effects (3) 3
time factors (3) 3
acs (2) 2
acute myocardial-infarction (2) 2
angioplasty (2) 2
bleeding (2) 2
care and treatment (2) 2
chi-square distribution (2) 2
complications (2) 2
consortia (2) 2
coronary angiography (2) 2
coronary artery disease - diagnosis (2) 2
coronary artery disease - therapy (2) 2
coronary thrombosis - etiology (2) 2
diabetes (2) 2
drug dosages (2) 2
infusions, intravenous (2) 2
insights (2) 2
ischemia (2) 2
laboratories (2) 2
logistic models (2) 2
management (2) 2
myocardial infarction (2) 2
myocardial infarction - etiology (2) 2
odds ratio (2) 2
outcomes (2) 2
percutaneous coronary intervention - adverse effects (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (2) 2
predictors (2) 2
prospective studies (2) 2
purinergic p2y receptor antagonists - administration & dosage (2) 2
sects (2) 2
stable angina (2) 2
stents (2) 2
studies (2) 2
ticlopidine - therapeutic use (2) 2
united states (2) 2
10043 (1) 1
10149 (1) 1
10162 (1) 1
10194 (1) 1
abciximab (1) 1
acuity trial (1) 1
acute coronary syndrome - blood (1) 1
acute coronary syndrome - diagnosis (1) 1
acute coronary syndrome - mortality (1) 1
acute coronary syndrome - therapy (1) 1
adenosine - analogs & derivatives (1) 1
adenosine - therapeutic use (1) 1
adenosine monophosphate - therapeutic use (1) 1
adjustment (1) 1
administration, oral (1) 1
adp, adenosine diphosphate (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 1, pp. 6 - 16
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 188, pp. 147 - 155
Objective To examine the safety and efficacy of cangrelor in patients with single-vessel disease (SVD) and multi-vessel disease (MVD). Background Cangrelor, an... 
Cardiovascular | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | PRACTICE GUIDELINES | MANAGEMENT | PLATELET INHIBITION | ACUTE MYOCARDIAL-INFARCTION | AMERICAN-COLLEGE | ELEVATION | ASSOCIATION TASK-FORCE | ANTIPLATELET THERAPY | STRATEGIES | Myocardial Infarction - epidemiology | Purinergic P2Y Receptor Antagonists - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Incidence | Dose-Response Relationship, Drug | Time Factors | Ticlopidine - administration & dosage | Female | Survival Rate - trends | Double-Blind Method | Global Health | Administration, Oral | Postoperative Complications - epidemiology | Ticlopidine - analogs & derivatives | Coronary Angiography | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Cause of Death - trends | Aged | Myocardial Infarction - prevention & control | Infusions, Intravenous | Percutaneous Coronary Intervention | Transluminal angioplasty | Medicine, Experimental | Medical research | Care and treatment | Cardiac patients | Myocardial infarction | Intervention | Surgical implants | Intravenous administration | Heart attacks | Laboratories | Angioplasty | Clinical trials | Cardiovascular disease | Grafting | Bleeding | Clinical outcomes | Consortia | Ischemia | Blood platelets | Motivation | Risk assessment | Implants | Electrocardiography | Safety | Thromboembolism | Stents | Drug dosages | Hypertension | Anticoagulants | Cerebral infarction | Stroke | Effectiveness | Adjustment | Hyperlipidemia | Complications | Mortality | Diabetes mellitus | Coronary artery | Angina pectoris | Patients | Thrombosis | Coronary vessels | Clopidogrel | Death | Infarction | Acute coronary syndromes | Bypasses
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 1, pp. 15 - 20
Objectives The purpose of this study was to determine whether, in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary... 
Cardiovascular | Internal Medicine | bivalirudin | complications | prognosis | myocardial infarction | angioplasty | Sects | Anticoagulants (Medicine) | Glycosaminoglycans | Mortality | Studies | Confidence intervals | Heart attacks | Coronary vessels | Cardiovascular disease | Diabetes | Drug therapy | Age | Blood | Risk factors
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 5, pp. 596 - 598
  [...]in some instances, pre-specified criteria were inconsistent with what was done in the review (e.g., the investigators' bleeding definition attempted to... 
Cardiovascular | Internal Medicine | Cardiology | Continuing medical education | Cardiac patients | Confidence intervals | Heart attacks | Laboratories | Coronary vessels | Clinical trials | Acute coronary syndromes
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 18, pp. 1905 - 1913
Abstract Objectives The purpose of this study was to examine the safety and efficacy of cangrelor in patients with stable angina (SA) or acute coronary... 
Cardiovascular | ACS | CHAMPION PHOENIX | Cangrelor | stable angina | PCI
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 1, pp. 214 - 220
Abstract Objectives This study sought to determine clinical, procedural, and treatment factors associated with acute stent thrombosis (AST) in the EUROMAX... 
Cardiovascular | percutaneous coronary intervention | bivalirudin | ST-segment elevation myocardial infarction | stent thrombosis
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 3, pp. 424 - 433
Abstract Objectives The aim of this study was to examine the efficacy and bleeding outcomes of cangrelor in patients in the CHAMPION PHOENIX (A Clinical Trial... 
Cardiovascular | CHAMPION PHOENIX | cangrelor | bivalirudin | stent thrombosis
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 09/2016, Volume 9, Issue 18, pp. 1905 - 1913
Objectives The purpose of this study was to examine the safety and efficacy of cangrelor in patients with stable angina (SA) or acute coronary syndrome (ACS).... 
ACS | CHAMPION PHOENIX | Cangrelor | stable angina | PCI | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | TICAGRELOR | PHOENIX | ANTIPLATELET | CLOPIDOGREL | THERAPY | PRETREATMENT | CHAMPION | PREDICTORS | PLATELET INHIBITION | EURO HEART SURVEY | PRASUGREL | Purinergic P2Y Receptor Antagonists - administration & dosage | Angina, Stable - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Purinergic P2Y Receptor Antagonists - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Odds Ratio | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Angina, Stable - therapy | Double-Blind Method | Angina, Stable - diagnosis | Risk Factors | Logistic Models | Treatment Outcome | Chi-Square Distribution | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - blood | Adenosine Monophosphate - adverse effects | Angina, Stable - blood | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Aged | Coronary Thrombosis - etiology | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Journal Article